Development of an MR-compatible respiratory control system

开发兼容 MR 的呼吸控制系统

• 批准号: 477345-2014
• 负责人: Chronik, Blaine
• 金额: $ 1.82万
• 依托单位: University of Western Ontario
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=565749
• 关键词: Development; MR; compatible; respiratory; control

Adjuvant Therapeutics Inc. is a medical device company based in Halifax, focused on providing systems and methods for control of in vivo oxygenation levels in humans. Adjuvant Therapeutics needs to use MRI as a platform in order to provide real-time in-vivo feedback of changes in tissue oxygenation brought about by respiratory control of oxygen and carbon dioxide. In order to achieve this, their existing prototype system must be evaluated and substantially modified in order to operate within the MRI. Dr. Chronik's research group at Western University specializes in the development and testing of MR-compatible medical devices and technology. His group also has full access to industry standard MRI systems at 1.5 T, 3 T and Canada's only 7-T MRI system. It is the ability to conduct comprehensive analysis and testing of medical devices across a wide range of MR platforms that is critical to addressing the challenges for the proposed Adjuvant Medical system.

佐剂治疗公司是一家总部位于哈利法克斯的医疗器械公司，专注于提供控制人体体内氧合水平的系统和方法。辅助治疗需要以MRI为平台，实时反馈呼吸控制氧气和二氧化碳所带来的组织氧合变化。为了实现这一目标，必须对现有的原型系统进行评估并进行实质性修改，以便在MRI内运行。Chronik博士在西部大学的研究小组专门从事核磁共振兼容医疗设备和技术的开发和测试。他的团队还拥有1.5 T， 3t和加拿大唯一的7-T MRI系统的行业标准MRI系统。这是在广泛的MR平台上对医疗器械进行全面分析和测试的能力，这对于解决拟议的辅助医疗系统的挑战至关重要。